Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report

  • Authors:
    • Shiue‑Wei Lai
    • Tzu‑Chuan Huang
    • Jia‑Hong Chen
    • Yi‑Ying Wu
    • Ping‑Ying Chang
  • View Affiliations

  • Published online on: February 3, 2015     https://doi.org/10.3892/ol.2015.2928
  • Pages: 1957-1961
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

BCR‑ABL tyrosine‑kinase inhibitors are the first‑line therapy for the majority of patients with chronic myelogenous leukemia (CML). Up to 20% of patients who have imatinib‑treated CML in blast crisis (BC) experience a relapse in the central nervous system (CNS) due to the poor penetration of the drug by the blood‑brain barrier. The present case reports a successful experience of using dasatinib‑based combination therapy to treat a 22‑year‑old female who presented with initial symptoms of intermittent fever and easy bruising under the diagnosis of CML in BC. Although the patient eventually succumbed to profound sepsis, the CNS involvement was treated successfully using dasatinib-based combination therapy (cranial radiation and de-escalated intrathecal chemotherapy). This case demonstrates that dasatinib may be a viable option for those who are not medically fit for or are otherwise unwilling to receive high‑dose chemotherapy. It appears that dose intensity is essential for optimal efficacy and should be maintained at 150 mg daily as far as possible.
View Figures
View References

Related Articles

Journal Cover

April-2015
Volume 9 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lai SW, Huang TC, Chen JH, Wu YY and Chang PY: Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report. Oncol Lett 9: 1957-1961, 2015
APA
Lai, S., Huang, T., Chen, J., Wu, Y., & Chang, P. (2015). Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report. Oncology Letters, 9, 1957-1961. https://doi.org/10.3892/ol.2015.2928
MLA
Lai, S., Huang, T., Chen, J., Wu, Y., Chang, P."Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report". Oncology Letters 9.4 (2015): 1957-1961.
Chicago
Lai, S., Huang, T., Chen, J., Wu, Y., Chang, P."Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report". Oncology Letters 9, no. 4 (2015): 1957-1961. https://doi.org/10.3892/ol.2015.2928